Recently, the “Chinese Center for Disease Control and Prevention Weekly” (English) disclosed 3 confirmed cases of the new coronavirus entering Chongqing. Genome sequencing found that the virus infected by these 3 confirmed patients was a variant virus circulating in India. It is speculated that the infection may occur. in India. The three confirmed patients (aged between 20-30) are from the same mobile phone company, which has a production base in Noida, India, where they have been working with their Indian colleagues since the end of 2019.
This matter needs to be analyzed in connection with the death of Indian-American infectious disease expert Rajendra Kapila (Rajendra Kapila) after contracting the new crown virus in India. On May 3, Indian-American infectious disease expert Rajendra Kapila (Rajendra Kapila) died after contracting the new crown virus in India. Because he had completed two injections of Pfizer’s new coronavirus vaccine before going to India. The American Indian-born infectious disease expert Rajadha Kapila was infected with the new coronavirus in India, which should be a mutated new coronavirus. We analyze the important points of these two things from several aspects. 1. Before returning to India from the United States, Jadra Kapila had been injected with two shots of Pfizer’s new crown vaccine, but he was quickly infected with the Indian variant of the new crown virus in India. This shows that the existing Pfizer new crown vaccine may be very low effective against the Indian mutant virus and cannot resist the infection of the Indian mutant virus. 2. As a professional infectious disease expert, Jadra Kapila has worked in New Jersey Medical and Dental University Hospital for more than 20 years. Therefore, he must have a very clear understanding of the epidemic prevention knowledge of the new crown virus, and he should have taken adequate epidemic prevention measures. 3. Three people from Chongqing who returned from India were infected with the mutant new coronavirus. They returned from India wearing protective clothing and found that they had contracted new coronary pneumonia after entering the country. It is worth noting that these personnel passed a nucleic acid test in India before boarding, and they were all negative. Earlier on April 4, 53 people were diagnosed with new coronary pneumonia on a 188-person flight from New Delhi to Hong Kong. This means that the credibility of India’s new coronavirus accounting test report is very low, or there is a large-scale fraud. The samples of the confirmed patients were tested at the Chongqing Centers for Disease Control and Prevention. Analysis showed that these isolates belonged to the Pangolin lineage B.1.617, which is an emerging variant found in India. Therefore, the infection of these three patients may have occurred in India. B.1.617 is that scientists discovered a mutated new coronavirus in India. This newly discovered mutant virus is more infectious and has a higher incidence. Therefore, B.1.617 is very likely to be one of the reasons for the recent worsening of the epidemic in India. At present, the mutated strains found in India have spread outward, mainly in India, the United Kingdom, the United States, Singapore, and Europe and other countries. The infection rate of the mutant new coronavirus that caused the second wave of the epidemic in India is very high, and the virus has a strong transmission capacity and is more destructive than people can imagine. India is now climbing the peak of the second wave of the epidemic, and there is still a long time before the summit. At the same time, the second wave of the new crown virus has crossed the border of India and spread to neighboring countries.